Salacca zalacca (Arecaceae) Snake Fruit, Salak, Salak Palm
Salacca zalacca is a spiny clustering palm of Southeast Asia whose fruit, known as "snake fruit" for its reddish-brown scaly skin, has generated a focused preclinical literature on its antidiabetic properties. Unlike many species in this series, the evidence here is mechanistically consistent: multiple independent studies demonstrate α-glucosidase inhibition across fruit, peel, and seed preparations, with a 60% ethanolic fruit extract achieving an IC50 of 16.2 μg/mL in one assay and significantly lowering serum glucose in obese-diabetic rats at 400 mg/kg over six weeks . The seed extract showed even more potent α-glucosidase inhibition (IC50 16.28 μg/mL) with a non-competitive mechanism, and an LD50 exceeding 2000 mg/kg . The peel, typically discarded, shows comparable antioxidant activity to the fruit and inhibits both α-amylase (90%) and ACE (98%) in vitro . However, no human clinical trials exist, and a 2018 review explicitly noted that investigation into the mode of action is "still lacking" .
---
1. Taxonomic Insights
Species: Salacca zalacca (Gaertn.) Voss
Family: Arecaceae (Palm Family)
Genus: Salacca
Synonyms: Salacca edulis Reinw. ex Blume, Zalacca edulis (Reinw. ex Blume) Reinw. ex Blume
---
Botanical Description
Salacca zalacca is a relatively small, extremely spiny, creeping and tillering palm, almost stemless, reaching 1 to 5 metres in height and growing in compact clumps . It is dioecious, though some forms (e.g., Salak Bali) are monoecious and self-pollinating .
Key Identification Features:
Leaves are pinnate, 4 to 10 metres long, with a 2-metre spiny petiole and numerous leaflets 20 to 89 centimetres long. Long, strong, grey to blackish spine clusters are distributed along the frond base at intervals of 3 to 5 centimetres . The fruit grows in clusters of 15 to 40 per spadix at the base of the palm. It is drupe-shaped, oval or spindle-like, 5 to 8 centimetres long and 5 centimetres wide, with a distinct pointed tip and a reddish-brown, scaly skin resembling snake scales . The flesh is creamy white, juicy and crunchy, with a sweet to sourish-sweet taste and slight astringency .
Distribution: Native to Indonesia and other Southeast Asian countries. Widely cultivated in the Malay Archipelago, with over 30 cultivars in Indonesia distinguished by origin, taste, or colour .
Conservation Status: Not assessed as threatened. Extensively cultivated across its native range.
---
Etymology
The generic name Salacca is derived from the Malay/Indonesian word "salak," the local name for the fruit. The specific epithet zalacca is a Latinized form of the same vernacular name.
---
2. Common Names
Scientific Name: Salacca zalacca | English: Snake Fruit, Salak, Salak Palm, Lizard-Skinned Salak | Indonesian: Salak | Malay: Salak | Thai: Sala | Filipino: Sala | German: Schlangenfrucht | French: Fruit Serpent | Chinese: 蛇皮果
---
3. Related Herbs from the Arecaceae Family
The Arecaceae family is economically significant for food (coconut, date, sago), timber, and thatching. Salacca zalacca is distinctive within the family for its medicinal research profile, particularly antidiabetic activity. Other Salacca species are primarily valued as food or ornamental plants, and the family does not contain the concentration of pharmacologically studied species found in families like Asteraceae or Rutaceae.
---
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions:
Antidiabetic / α-Glucosidase Inhibition (Fruit, Seed, Peel): This is the most extensively investigated activity. A 60% ethanolic fruit extract inhibited α-glucosidase with an IC50 of 16.2 μg/mL in one study . In obese-diabetic rats, administration of 400 mg/kg body weight for six weeks significantly lowered serum glucose and improved lipid profiles . The seed extract inhibited α-glucosidase non-competitively (IC50 16.28 μg/mL, Ki 24.81 μg/mL) and reduced fasting blood glucose in an oral glucose tolerance test in diabetic mice . The peel extract inhibited α-amylase (90%) and ACE (98%) in vitro .
Antihypertensive / ACE Inhibition (Peel): The peel extract demonstrated 98% ACE inhibition in vitro, suggesting potential antihypertensive activity .
Antioxidant (Fruit, Peel, Seed): The fruit pulp contains significant phenolic content (257.17 μL/mL) and antioxidant activity (10.56 μM TE/g) . The peel showed comparable antioxidant activity to the fruit, with the highest concentrations of chlorogenic, caffeic, and ferulic acids at 30 days after flowering .
Secondary Actions (Preclinical):
· Anticancer (Fruit): β-Sitosterol (3-hydroxystigmastan-5(6)-en) isolated from the fruit inhibited proliferation of MCF-7 and T47D breast cancer cell lines with IC50 values of 45.41 and 1.19 μg/mL, respectively .
· Anti-aging / Cellular Antioxidant (Fruit): The ethyl acetate extract reduced H2O2-mediated fibroblast cell death at 5 to 40 μg/mL, indicating cellular antioxidant potential .
· Antimicrobial (Peel, Pulp): Extracts showed activity against Staphylococcus aureus and Escherichia coli, with the pulp at mid-ripeness exhibiting the most potent activity .
---
Medicinal Parts
Fruit (Pulp): The primary edible and studied part. Rich in phenolics (chlorogenic acid predominant) and demonstrates α-glucosidase inhibition and antidiabetic activity in animal models .
Seed: Demonstrates potent non-competitive α-glucosidase inhibition and postprandial anti-hyperglycemic effects in mice, with no toxicity at 2000 mg/kg . Contains flavonoids, tannins, and alkaloids .
Peel: Typically discarded but shows comparable antioxidant activity to the fruit and significant α-amylase and ACE inhibition in vitro . Contains high concentrations of chlorogenic, caffeic, and ferulic acids .
---
5. Phytochemistry
5.1 Phenolic Compounds (Fruit Pulp)
Chlorogenic acid is the predominant phenolic compound in the pulp, followed by epicatechin, isoquercetin, neochlorogenic acid, ferulic acid, gallic acid, procyanidin B2, syringic acid, and caffeic acid . A 60% ethanolic extract contained gallic acid, caffeic acid, (-)-epicatechin, and ferulic acid, confirmed by HPLC-MS/MS .
5.2 Phenolic Compounds (Peel)
The peel contains the highest concentrations of chlorogenic acid (705.0 mg/100 g DW), caffeic acid (321.0 mg/100 g DW), and ferulic acid (173.5 mg/100 g DW) at 30 days after flowering .
5.3 Seed Compounds
The seed extract shows a prominent HPLC peak corresponding to chlorogenic acid . Secondary metabolites include flavonoids (0.059%), tannins (0.082%), and alkaloids (0.063%) .
5.4 Other Compounds
β-Sitosterol (3-hydroxystigmastan-5(6)-en) was isolated from the fruit and demonstrated cytotoxicity against breast cancer cell lines . The fruit also contains vitamin C, carotenoids, and organic acids (malic acid predominant in pulp) .
---
6. Mechanisms of Action
6.1 Antidiabetic Activity (α-Glucosidase Inhibition)
The fruit, seed, and peel extracts inhibit α-glucosidase, the enzyme that breaks down complex carbohydrates into absorbable monosaccharides in the small intestine. The seed extract acts as a non-competitive inhibitor (Ki 24.81 μg/mL), binding to a site other than the active site . This inhibition slows glucose absorption, reducing postprandial blood sugar spikes.
6.2 Antidiabetic Activity (Glucose Uptake Inhibition)
The seed extract also inhibited glucose uptake in Caco-2 intestinal cells in a concentration-dependent manner, suggesting a dual mechanism of reducing glucose absorption .
6.3 Antihypertensive Activity (ACE Inhibition)
The peel extract inhibited angiotensin-converting enzyme (ACE) by 98% in vitro, the enzyme responsible for converting angiotensin I to the vasoconstrictor angiotensin II . This suggests a mechanism for potential blood pressure-lowering effects, though this has not been tested in vivo.
6.4 Antioxidant Activity
The phenolic compounds (chlorogenic acid, caffeic acid, ferulic acid, epicatechin) provide free radical scavenging capacity, protecting cells from oxidative stress .
---
7. Traditional and Ethnobotanical Uses
7.1 Diabetes (Fruit, Traditional)
Formulation: Fruit consumed fresh or as extract.
Preparation and Use: S. zalacca fruit is traditionally used in South Asian medicine as a natural remedy to prevent and treat diabetes mellitus .
Scientific Validation: Multiple preclinical studies support this use through α-glucosidase inhibition and in vivo glucose reduction. However, no human clinical trials exist.
7.2 Food (Fruit)
The ripe fruit flesh is sweet and mostly eaten fresh. It may also be candied or canned, and unripe fruits are used as pickles .
---
8. Healing Recipes, Teas, Decoctions, and Culinary Uses
8.1 Fresh Snake Fruit
Purpose: A nutritious snack with sweet-tart flesh.
Preparation and Use: The scaly skin is peeled away to reveal the creamy white flesh, which is eaten fresh. The flesh is juicy and crunchy with a sweet to sourish-sweet taste .
8.2 Salak Fruit Tea (Traditional/Commercial Product)
Purpose: A healthy beverage rich in antioxidants.
Preparation and Use: Salak fruit is combined with pineapple and longan (ratio 20:20:60) and 20% (w/w) Schizophyllum commune (hed krang) to make a fruit tea. Sensory evaluation indicated good consumer acceptance .
---
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Antidiabetic (Fruit): Moderate evidence from in vivo animal study. 60% ethanolic extract at 400 mg/kg for 6 weeks significantly lowered serum glucose and improved lipid profiles in obese-diabetic rats . In vitro α-glucosidase inhibition IC50 16.2 μg/mL . No human clinical trials.
Antidiabetic (Seed): Moderate evidence from in vivo animal study. Non-competitive α-glucosidase inhibition (IC50 16.28 μg/mL), reduced postprandial glucose in OGTT in diabetic mice . No human clinical trials.
Antihypertensive (Peel): Preliminary in vitro evidence. 98% ACE inhibition by methanol/ethanol peel extracts . No animal or human studies.
Anticancer (Fruit): Preliminary in vitro evidence. β-Sitosterol inhibited MCF-7 and T47D proliferation (IC50 45.41 and 1.19 μg/mL) . No animal or human studies.
Critical Gap: Despite consistent preclinical evidence across multiple studies, no human clinical trials exist for any indication. A 2018 review explicitly noted that "investigation on the mode of action is still lacking" .
---
10. Safety and Toxicology
10.1 Toxicity Profile
Seed Extract: The estimated LD50 exceeds 2000 mg/kg, and no toxicity symptoms were detected in acute toxicity testing . A subchronic toxicity study on liver function in mice was conducted, though specific results were not detailed in the available abstract .
Fruit: Consumed as food with a long history of traditional use. No known hazards for human consumption at normal dietary levels.
Peel: A 2025 zebrafish embryo study is investigating the toxicity and teratogenicity of the ethanol peel extract in a high-glucose context, but results are not yet available .
10.2 Contraindications and Precautions
Pregnancy and Lactation: The fruit is a food. No safety data exist for concentrated extracts. Consult a healthcare provider.
Diabetes Medications: The plant has demonstrated significant α-glucosidase inhibition and glucose-lowering effects in animals. Additive effects with antidiabetic medications are theoretically possible, and blood glucose should be monitored if combined .
10.3 Potential Drug Interactions
No formal drug interaction studies were found. Based on the demonstrated α-glucosidase inhibition and ACE inhibition , there is a theoretical potential for additive effects with antidiabetic and antihypertensive medications, respectively.
---
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
For Fruit: Chlorogenic acid is the predominant phenolic compound and a suitable marker . Total phenolics and total flavonoids are functional markers for antioxidant capacity.
For Seed: Chlorogenic acid is the prominent peak in HPLC and a marker for α-glucosidase inhibitory activity .
11.2 Recommended Analytical Methods
HPLC for quantification of phenolic compounds (chlorogenic acid, caffeic acid, epicatechin, ferulic acid) . Spectrophotometric assays for total phenolics (Folin-Ciocalteu) and antioxidant capacity (DPPH, ABTS) .
11.3 Suggested Specifications
No official pharmacopoeial specifications exist. For research-grade fruit extracts, specifications would include minimum chlorogenic acid content and verified α-glucosidase inhibitory activity.
---
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: Humid tropics, at elevations between sea level and 500 metres .
Habitat: Prefers moist, well-drained soil with high organic matter content. Requires shade and is best intercropped with banana, durian, rubber, oil palm, coconut, or cocoa .
Propagation: Starts flowering about 3 to 4 years after sowing. Harvesting takes place at a fruit age of 5 to 7 months. The palm can be productive for several decades .
12.2 Sustainable Harvesting
The fruit is the primary harvest. The peel, typically discarded, has been identified as a valuable source of bioactive compounds, offering a valorization opportunity for the food industry .
12.3 Conservation Status
Not assessed as threatened. Widely cultivated across Southeast Asia.
---
13. Research Gaps and Future Directions
13.1 Critical Research Gaps
Human Clinical Trials: There are zero human clinical trials for any medicinal use of S. zalacca. All evidence is from in vitro and animal studies.
Mode of Action: The 2018 review explicitly noted that investigation into the mode of action is "still lacking" . While α-glucosidase inhibition is established, downstream metabolic effects require further elucidation.
Peel Valorization: The peel shows promising ACE and α-amylase inhibition but has not been tested in vivo.
Long-Term Safety: Subchronic toxicity data are limited, and the zebrafish embryo study results are pending .
13.2 Future Research Priorities
Clinical Translation: A Phase I/II trial of a standardized fruit or seed extract in type 2 diabetic patients, building on the consistent preclinical data .
Peel Extract Development: In vivo testing of the peel extract for antihypertensive and antidiabetic effects, given the 98% ACE inhibition and 90% α-amylase inhibition observed in vitro .
---
14. Commercial Applications
14.1 Pharmaceutical and Nutraceutical Potential
Antidiabetic Nutraceutical (Promising): The combination of α-glucosidase inhibition, in vivo glucose reduction, and low toxicity (LD50 > 2000 mg/kg for seed) positions S. zalacca as a candidate for functional food or supplement development .
14.2 Application-Specific Product Development
Salak Fruit Tea: A commercial product combining salak with pineapple and longan, leveraging its antioxidant content .
Seed-Based Supplement: A caffeine-low, antioxidant-rich seed extract for postprandial glucose management, pending clinical validation .
---
15. Related Plants for Further Study
The Arecaceae family is not known for concentrated medicinal species in the way that families like Asteraceae or Rutaceae are. Salacca zalacca is distinctive within its family for its antidiabetic research profile. Comparative studies with other Salacca species could reveal whether the α-glucosidase inhibitory activity is genus-wide or species-specific.
---
16. Reference Literature
Primary Research
· Saleh, M.S.M., et al. (2020). "Modulation of metabolic alterations of obese diabetic rats upon treatment with Salacca zalacca fruits extract using 1H NMR-based metabolomics." Food Research International. Key in vivo antidiabetic study .
· Sato, V.H., et al. (2023). "Oral Glucose Tolerance Test (OGTT) Evidence for the Postprandial Anti-Hyperglycemic Property of Salacca zalacca Seed Extract." Molecules 28(19). Key seed extract study with α-glucosidase inhibition and LD50 data .
· (2025). "Dynamics of Bioactive Compounds and Their Relationship with Antioxidant and Antimicrobial Activity in the Pulp, Peel, and Seeds of 'Salak' During Ripening." Europe PMC. Comprehensive phenolic and antioxidant profiling .
· (2020). "Antioxidant, hypoglycemic and anti-hypertensive properties of extracts derived from peel, fruit and kernel of Salak." ScienceDirect. ACE and α-amylase inhibition data for peel .
· Saleh, M.S.M., et al. (2018). "Salacca zalacca: A short review of the palm botany, pharmacological uses and phytochemistry." Asian Pacific Journal of Tropical Medicine 11(12): 645-652. Review noting research gaps .
Key Monographs and Floras
· FAO Ecocrop: Botanical description, uses, and cultivation requirements .
· ScienceDirect Topics: Cultivar information and fruit characteristics .
· AGRIS (FAO): Phenolic compound profiling of fruit pulp .
---
17. Disclaimer
The fruit of Salacca zalacca is consumed as a food with a long history of traditional use.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Medicinal applications of fruit, seed, and peel extracts lack human safety and efficacy data. All therapeutic applications remain investigational.
Individuals with diabetes or hypertension should not replace prescribed medications with this plant without consulting a healthcare provider. Blood glucose and blood pressure should be monitored if combining with medications due to the potential for additive effects.
Proper identification is crucial. Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.

Comments